Pharmaceutical compositions comprising at least one compound of the formulas (Ia) or (Ib) or (IIa) or (IIb) and a pharmaceutically acceptable carrier wherein the symbols and substituents have the following meaning -X- is e.g. and Y being e.g. or the pharmaceutically acceptable salts can be applied to modulate the in- vitro and in- vivo binding processes mediated by E-, P- or L-selectin binding.
申请公布号
WO2007039111(A3)
申请公布日期
2007.06.14
申请号
WO2006EP09152
申请日期
2006.09.20
申请人
REVOTAR BIOPHARMACEUTICALS AG;AYDT, EWALD;KRANICH, REMO;BUSEMANN, ANKE